Policy Seminar
The Policy Seminar is held once a year as an activity to strengthen understanding and support for the current situation and issues surrounding the JPMA industry, as well as to promote the JPMA's advocacy.
- *(Affiliations and positions are as of the time of the seminar)
-
Policy Seminar
Toward a Nation Driven by Innovation: Strengthening Japan's Drug Discovery Capabilities and Universal Health Coverage
Mr. Norihisa Tamura, Member of the House of Representatives, Acting Chairman of the Policy Research Council of the Liberal Democratic Party / Former Minister of Health, Labor and Welfare
Mr. Teruyuki Katori, President, Future Research Institute Garyu / Specially Appointed Professor, Graduate School of Social Sciences, University of Hyogo
Mr. Shinsuke Amano, President, National Federation of Cancer Patients' Associations
Ms. Chizuko Furuseki, President, Tagusix Bio Inc.
Hiroaki Ueno, Chairman, Japan Pharmaceutical Manufacturers Association
Mr. Jun Ando, Editorial Writer, Nikkei Inc. -
Policy Seminar
Toward the Creation of Innovative New Drugs from Japan: Building a Healthcare Ecosystem for Continuous Innovation
Mr. Akira Amari, Member of the House of Representatives, Chairman, Economic Security Task Force, Liberal Democratic Party of Japan
Mr. Hisashi Yoshizawa, Attorney at Law, Director, GRiT Partners Law Office / Expert on Biotechnology Strategy, Cabinet Office
Mr. BT Slingsby, Founder & Managing Partner, Catalys Pacific
Ms. Yuko Kuno, Serial Entrepreneur, Director & Co-Founder, Phoenixi
Haruhiko Morita, President & CEO, Modaris
Noriichi Kubota, President & CEO, KSP / Founder, PeptiDream
Dr. Tomoyoshi Koyanagi, Professor, University of Tsukuba, Tsukuba, Japan / Director, TR Promotion and Education Center, Tsukuba Clinical Medical Research and Development Organization
Mr. Kozo Saeki, Director, Biological Chemical Industry Division, Commerce and Service Group, Ministry of Economy, Trade and Industry
Mr. Yasushi Okada, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
Toward Revival of Japan's Innovation Creation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinvigoration?
D., Graduate School of Tsukuba University / Ph.D. Fellow, Google-Microsoft Research, University of Tsukuba Dr. Daimu Yakura
Professor, Graduate School of Science, Technology and Innovation, Kobe University / President and CEO, Simplogen (concurrent position) Mr. Kazuhiko Yamamoto
Executive Officer and Vice President, The University of Tokyo / Professor, Future Vision Research Center, The University of Tokyo Toshiya Watabe
Professor, School of Science and Engineering, Waseda University / President, DEN Mii Clinic, Waseda University Toshio Miyata
Mr. Tadashi Mogi, Deputy Director-General for Commerce and Service, Ministry of Economy, Trade and Industry
Mr. Toshihiro Maeta, President and Representative Director, MTI
Mr. Yasushi Okada, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era
Mr. Koichi Tanaka, Executive Research Fellow, Shimadzu Corporation / Director, Koichi Tanaka Memorial Mass Spectrometry Laboratory
Dr. Hiroyuki Mano, Director, National Cancer Center, Director of Cancer Genome Information Management Center, Director of Research Institute, National Cancer Center
Dr. Masayuki Yamamoto, Director, Tohoku Medical Megabank Organization, Tohoku University
Ms. Tamayo Marukawa, Member of the House of Councilors
Dr. Yasumasa Fukushima, Medical Technical Director, Ministry of Health, Labour and Welfare
Ms. Naomi Sakurai, President, Cancer Solutions, Inc.
Mr. Joji Nakayama, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
What can be achieved through innovation in pharmaceuticals - Contribution of new drugs, expectations and future challenges
Mr. Tadaharu Goto, President, Japan Pharmaceutical Manufacturers Association
Mr. Shinzo Abe, Prime Minister of Japan
Mr. Chenichi Eto, Advisor to the Prime Minister
Mr. Yasuhiro Suzuki, Director General, Medical Technology Bureau, Ministry of Health, Labour and Welfare
H.R.H. Princess Hashemite of Jordan / Ms. Dina Millouad, President, International Union Against Cancer
Hiroki Nakatani, Professor, Global Research Institute, Keio University / President, Global Health Technology Fund
Dr. Satoshi Omura, Nobel Laureate in Physiology or Medicine / Distinguished Professor Emeritus, Kitasato University
Dr. Hiroko Otsubo, Deputy Director, Health and Medical Strategy Office, Cabinet Secretariat
Dr. Hiroyuki Mano, Director-General, National Cancer Center/ Director, Cancer Genome Center
Mr. Yoshiyuki Majima, President, PanCan Japan, a non-profit organization
Mr. Joji Nakayama, Chairman, Japan Pharmaceutical Manufacturers Association -
Policy Seminar
The Turning Point in Healthcare and the Pharmaceutical Industry: Promoting the Utilization of Medical Big Data
Mr. Tadaharu Goto, President, Japan Pharmaceutical Manufacturers Association
Hiroyuki Yoshihara, Professor Emeritus, Kyoto University and University of Miyazaki
Atsushi Otsu, Director, National Cancer Center Hospital East
Mr. Toshihisa Okamoto, Counselor, Health and Medical Strategy Office, Cabinet Secretariat
Mr. Yoshihiko Hatanaka, Chairman, Japan Pharmaceutical Manufacturers Association
Hiroaki Miyata, Professor, Department of Health Policy and Management, Keio University School of Medicine -
Policy Seminar
Drug Discovery Innovation and the Future of the Pharmaceutical Industry
Mr. Tadaharu Goto, President, Japan Pharmaceutical Manufacturers Association
Makoto Suematsu, President, Japan Agency for Medical Research and Development
Dr. Keiko Morimitsu, Director, Research and Development Promotion Division, Medical Policy Bureau, Ministry of Health, Labour and Welfare
Keita Mori, President and Representative Director, Sunbio Inc.
Yoshihiko Hatanaka, Chairman, Japan Pharmaceutical Manufacturers Association
Hiroaki Miyata, Professor, Department of Medical Policy and Management, Faculty of Medicine, Keio University -
Policy Seminar
Questioning the Value of Pharmaceuticals - Considering the Evaluation of Innovation in the National Health Insurance System
Tadaharu Goto, President, Japan Pharmaceutical Manufacturers Association
Sadao Nagaoka, Professor, Faculty of Economics, Tokyo Keizai University
Tomohiro Onishi, Director, Economic Affairs Division, Medical Policy Bureau, Ministry of Health, Labour and Welfare
Hisao Endo, Professor, Faculty of Economics, Gakushuin University
Mr. Yoshihiko Hatanaka, Chairman, Japan Pharmaceutical Manufacturers Association
Mr. Manyo Mita, Senior Advisor, Investment Banking Division, Mitsubishi UFJ Morgan Stanley Securities Co.